In yesterday’s Wall Street session, Rockwell Medical Inc. (NASDAQ:RMTI) shares traded at $3.58, up 6.87% from the previous session.
As of this writing, 1 analysts cover Rockwell Medical Inc. (NASDAQ:RMTI). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $11.00 and a low of $11.00, we find $11.00. Given the previous closing price of $3.35, this indicates a potential upside of 228.36 percent. RMTI stock price is now -11.31% away from the 50-day moving average and 62.76% away from the 200-day moving average. The market capitalization of the company currently stands at $95.41M.
There are 0 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $11.00 as their price target over the next twelve months.
With the price target of $10, Piper Jaffray recently initiated with Overweight rating for Rockwell Medical Inc. (NASDAQ: RMTI).
A total of 5.58% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in RMTI stock. A new stake in Rockwell Medical Inc. shares was purchased by STRATOS WEALTH PARTNERS, LTD. during the first quarter worth $538,000. VIRTU FINANCIAL LLC invested $115,000 in shares of RMTI during the first quarter. In the first quarter, SIGMA PLANNING CORP acquired a new stake in Rockwell Medical Inc. valued at approximately $90,000. NUVEEN ASSET MANAGEMENT, LLC acquired a new stake in RMTI for approximately $65,000. AMERITAS ADVISORY SERVICES, LLC purchased a new stake in RMTI valued at around $38,000 in the second quarter. In total, there are 43 active investors with 22.30% ownership of the company’s stock.
Friday morning saw Rockwell Medical Inc. (NASDAQ: RMTI) opened at $3.3600. During the past 12 months, Rockwell Medical Inc. has had a low of $0.84 and a high of $6.24. As of last week, the company has a debt-to-equity ratio of 0.74, a current ratio of 2.00, and a quick ratio of 1.60. The fifty day moving average price for RMTI is $4.0614 and a two-hundred day moving average price translates $2.2115 for the stock.
The latest earnings results from Rockwell Medical Inc. (NASDAQ: RMTI) was released for Mar, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.1, beating analysts’ expectations of -$0.16 by 0.06. This compares to -$0.84 EPS in the same period last year. The net profit margin was -17.40% and return on equity was -84.30% for RMTI. The company reported revenue of $19.67 million for the quarter, compared to $16.12 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 21.98 percent. For the current quarter, analysts expect RMTI to generate $18.08M in revenue.
